Elon Musk Drops Stunning Bombshell?
Behind closed doors, Musk revealed a game-changing breakthrough technology that could shake the tech world & crush major companies. Why is no one talking about it? Luckily, we had a man on the inside - watch now to see the details & how to profit!
UN official urges Israel to lift aid blockade of Gaza and calls it 'cruel collective punishment'
JERUSALEM (AP) — The United Nations’ emergency relief coordinator urged Israel on Thursday to lift its blockade of aid into the Gaza Strip, saying the amounts to “cruel collective punishment.”
Humana, Elevance, Aetna Face DOJ Lawsuit Over Illegal Kickback Scheme, Discrimination Against Disabled People
The lawsuit alleges that from 2016 through at least 2021, the insurers paid hundreds of millions of dollars in illegal kickbacks to brokers.
"Market Wizard " Thrives on Tariff Turmoil - Ad
Steel. Copper. Semiconductors. Another round of tariffs is rattling Wall Street, triggering panic selling. But history shows these policy moves don't just create losers - they create massive trading opportunities.
Lower Demand In China Disrupts Philips Q1 Sales, Cuts 2025 Profitability Target On Potential Tariff Impact
Philips topped Q1 profit estimates with €0.25 EPS, cut its 2025 margin outlook due to tariffs, and reported €1.09 billion cash outflow tied to U.S. settlements.
COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why
Novavax posts $667 million in Q1 2025 revenue and $2.93 EPS, boosted by Sanofi payments and APA terminations; full-year outlook raised above expectations.
Brace Yourself for Jeff Bezos' "Amazon Helios" - Ad
Amazon delivers 20 million packages a day... powers some of the most popular websites... delivers medication to half of the U.S. population... and even produces award-winning films and TV shows. But a Wall Street legend -- twice featured on 60 Minutes -- predicts that "Amazon Helios" will be bigger than all of those... COMBINED.
Sarepta Therapeutics Stock Sinks On Gloomy Forecast, Analysts Expect Demand To Pick Up
Sarepta posted a deeper-than-expected Q1 loss and cut its 2025 forecast due to Elevidys rollout delays, despite beating revenue estimates.
A New Gold Discovery in Red Lake? - Ad
Two new gold anomalies just lit up the maps. They sit right beside a restart-ready mine-and follow the exact fold pattern that's made Red Lake world famous.
Neurocrine Biosciences' Ingrezza Q1 Sales Prove Resilient, Analysts Boost Price Target
Neurocrine stock gains as Q1 EPS beats estimates; Ingrezza sales climb 8% YoY with record new patients and strong analyst price target hikes.
A Nebraska bill would criminalize hemp-based THC. Opponents say it could make grandma a felon
LINCOLN, Neb. (AP) — Kind Life Dispensary has been offering cannabinoid gummies, tinctures, ointments, now even canned beverages for seven years as one of the first businesses in Nebraska to offer such products. Founder and co-owner Andrea Watkins said her venture has been wildly successful, and she now has three locations in Nebraska's capital city that employ eight people and sell to hundreds of regulars who use the products to treat everything from aches and pains to anxiety and post traumatic stress disorder.
Elon's Greatest Invention... Hidden in South Memphis? - Ad
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon's greatest invention ever... Yes, even bigger than Tesla or SpaceX.
CDC Logs Highest Tuberculosis Caseload In A Decade — Advocates Warn WHO Pull-Out Leaves America Flying Blind
Global health experts warn that US retreat from TB prevention programs could lead to a resurgence of the deadliest infectious disease, as seen with a recent case in suburban Illinois.
What’s that rash? Put some thought into asking Google for medical help
Dr. Google is often on call for worried patients, but it may not give the best advice.
No.1 Opportunity for 2025 [Take Action Now!] - Ad
Starlink's potential IPO Could Be the Biggest in History--Silicon Valley insider James Altucher has uncovered a way to profit BEFORE the IPO--with as little as $50. Musk's $180B giant is set to launch--will you miss out? Claim your spot before it's too late.
Decision looming for Trump administration on first PFAS drinking water limits
In pain so bad he couldn’t stand, Chris Meek was rushed to the hospital with a life-threatening ruptured gallbladder. When he emerged from surgery, he learned he had kidney cancer that thankfully hadn’t yet spread.
UroGen Pharma Touts Four-Year Response With Urothelial Cancer Drug Study, Highlights Potential For Bladder Cancer Candidates
UroGen Pharma reports strong long-term data for Jelmyto and UGN-102 in cancer studies and shares promising early results for UGN-301 in bladder cancer.
Trump's Crypto Blueprint Unveils This Infrastructure Powerhouse - Ad
One blockchain token sits at the heart of Washington's pro-crypto agenda. Institutions are loading up while it still trades at a discount. Here's how to get in for $3.
USDA withdraws a plan to limit salmonella levels in raw poultry
The Agriculture Department will not require poultry companies in their products, halting a Biden Administration effort to prevent food poisoning from contaminated meat.
Novavax says its COVID-19 shot is on track for full FDA approval after delay
WASHINGTON (AP) — Novavax's closely watched is on track for full approval after additional discussions with the , the company said Wednesday.
Nvidia Is About to Shock the World: July 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: July 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
RFK Jr. plans to phase out eight artificial dyes from the US food supply
WASHINGTON (AP) — U.S. health officials said they plan to phase out eight petroleum-based artificial colors from the nation's food supply, triggering an overhaul of scores of brightly hued products on American store shelves.
Walgreens to pay up to $350 million in U.S. opioid settlement
Walgreens has agreed to pay up to $350 million in a settlement with the U.S. Department of Justice, who accused the pharmacy of in the last decade for opioids and other controlled substances.
Elon Musk Drops Stunning Bombshell? - Ad
Behind closed doors, Musk revealed a game-changing breakthrough technology that could shake the tech world & crush major companies. Why is no one talking about it? Luckily, we had a man on the inside - watch now to see the details & how to profit!
White House proposes eliminating Head Start funding as part of sweeping budget cuts
The Trump administration is asking Congress to a move that would cut early education for more than half a million of the nation’s neediest children and child care for their families.
Taking a mental health leave from work is an option most people don't know about
NEW YORK (AP) — Her first came at a company-wide meeting, right before her scheduled presentation. Carolina Lasso had given many similar talks about her marketing team's accomplishments. When her name was called this time, she couldn’t speak.
Gold Is Breaking Records. This Stock Hasn't Moved Yet. - Ad
With gold over $3,200, one near-term producer is still trading like a developer. But the mill is running, crews are working underground, and first production is months away.
Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion
Leqembi gains European approval after CHMP reversal, despite safety concerns tied to brain swelling and bleeding in Alzheimer's treatment.
European regulators OK Alzheimer's treatment Leqembi after initial doubts
European regulators have finally approved the Alzheimer’s treatment Leqembi after an advisory committee the drug last summer and then .
The Cross-Chain Giant Set for 1,000%+ Gains - Ad
This multi-chain protocol's volume is exploding while its price is still under the radar. Institutions are moving in fast-get our urgent report before retail wakes up.
Target baby food is recalled over lead contamination
A company that makes baby food sold under a Target store brand is recalling more than 25,000 packages of a product because it may contain elevated levels of lead.
Arkansas asks USDA to let it ban soda and candy from SNAP
LITTLE ROCK, Ark. (AP) — Arkansas officials moved Tuesday to ban soft drinks and candy that helps low-income people pay for groceries, becoming the first state to ask the Trump administration to let it restrict such items from the program long known as food stamps.
Biggest Dividend Payout in U.S. History: $1 Trillion up for Grabs! - Ad
Trump just launched a $1 trillion National Investment Fund to replace income taxes and send direct payouts to Americans. You could claim up to $21,307--before the first public checks go out. This is historic. Act now to be first in line.
FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting
FDA approves Argenx's Vyvgart Hytrulo prefilled syringe for self-injection in gMG and CIDP, offering flexible dosing and expanding treatment options.
Schools lined up for help getting cleaner school buses. Then came the EPA freeze
BOSTON (AP) — Looking to cut pollution from its fleet of diesel-burning school buses, an Oklahoma school district last year doubled its electric vehicles.
The Most Important "AI Stock" You've Never Heard Of - Ad
The AI revolution is moving faster than anyone expected. But what no one is talking about is the one company AI simply can't exist without. It may be the single most important AI investment, yet most people don't even know its name. For now. The moment Wall Street catches on, this $20 stock could explode.
A machine using ultrasound and IA can gauge the fattiness of a tuna fish
KAWASAKI, Japan (AP) — Seafood lovers know the fatty marbling is what makes tuna sashimi and sushi so tasty, so for the industry, it's the fish's level of fattiness that's used to judge its quality and pricing.
Sequencing Company PacBio Cuts Costs Amid Uncertainty Around NIH Funding And New Tariffs
PacBio reaffirms 2025 revenue outlook and unveils cost-cutting measures as Vega system demand grows and Revio usage meets expectations.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.